Related Experiment Video
Updated: Apr 20, 2026

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.7K
Rituximab induced psoriasis in an infant
Loretta Fiorillo1, Charles Wang, Imam Hemmati
1Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
Pediatric Dermatology
|November 27, 2014
Summary
Psoriasis onset after rituximab therapy is a rare occurrence, especially in children. This study details the first reported case of a 16-month-old boy developing psoriasis following rituximab treatment.
Area of Science:
- Immunology
- Dermatology
- Pediatrics
Background:
- Rituximab, a CD20-targeting monoclonal antibody, is utilized for various autoimmune conditions.
- While effective, rituximab's side effect profile includes potential dermatologic manifestations.
- Psoriasis development post-rituximab has not been previously documented in pediatric populations.
